BCHE and Alzheimer disease: Nevertheless, current therapeutic strategies for AD remain considerably limited, with only two alternatives available, including naturally derived and synthetic inhibitors or hybrid analogs to cholinesterase enzyme, and antagonists to N-methyl D-aspartate (NMDA).